Intrinsic Value of S&P & Nasdaq Contact Us

Cocrystal Pharma, Inc. COCP NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
66/100
3/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — COCP

Cocrystal Pharma, Inc. (COCP) has a market capitalization of $15.78M and trades at $1.54. The 52-week range is 0.86-2.67.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2, Earnings Per Share (EPS) of $-0.78.

The stock has a beta of 1.18, operates in the Healthcare sector.

Trading Data
Current Price$1.54
52-Week Range0.86-2.67
Volume291.66K
Avg Volume (30D)2.48M
Market Cap$15.78M
Beta (1Y)1.18
Company
IPO Date2012-02-22
Employees11
CEOSam Lee
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS19188J4094
CUSIP19188J300
Income (Latest Year)
EBITDA$-8.64M
Operating Income$-9.02M
Net Income$-8.83M
EPS$-0.78
EPS Diluted$-0.78
Shares Outstanding$11.29M
Balance Sheet (Latest Year)
Total Assets$9.71M
Current Assets$8.13M
Cash & ST Investments$7.03M
Total Liabilities$3.38M
Total Debt$1.51M
Net Debt$-5.52M
Total Equity$6.33M
Debt / Equity0.24
Valuation Ratios
P/E Ratio-2
P/B Ratio2.49
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message